302 related articles for article (PubMed ID: 32815186)
1. Acceptability of the health-related quality of life instrument EQ-5D-Y-5L among patients in child and adolescent psychiatric inpatient care.
Krig S; Åström M; Kulane A; Burström K
Acta Paediatr; 2021 Mar; 110(3):899-906. PubMed ID: 32815186
[TBL] [Abstract][Full Text] [Related]
2. EQ-5D-Y-5L as a patient-reported outcome measure in psychiatric inpatient care for children and adolescents - a cross-sectional study.
Åström M; Krig S; Ryding S; Cleland N; Rolfson O; Burström K
Health Qual Life Outcomes; 2020 Jun; 18(1):164. PubMed ID: 32493419
[TBL] [Abstract][Full Text] [Related]
3. [Development of the German version of EQ-5D-Y-5L to measure health-related quality of life in children and adolescents: Identification of response labels and pilot testing].
Kreimeier S; Greiner W
Z Evid Fortbild Qual Gesundhwes; 2019 Aug; 144-145():24-34. PubMed ID: 31378708
[TBL] [Abstract][Full Text] [Related]
4. Patient-caregiver agreement and test-retest reliability of the EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients with haematological malignancies.
Zhou W; Shen A; Yang Z; Wang P; Wu B; Herdman M; Luo N
Eur J Health Econ; 2021 Sep; 22(7):1103-1113. PubMed ID: 33950465
[TBL] [Abstract][Full Text] [Related]
5. Comparative Psychometric Performance of Common Generic Paediatric Health-Related Quality of Life Instrument Descriptive Systems: Results from the Australian Paediatric Multi-Instrument Comparison Study.
Jones R; O'Loughlin R; Xiong X; Bahrampour M; Devlin N; Hiscock H; Chen G; Mulhern B; Dalziel K;
Pharmacoeconomics; 2024 Jun; 42(Suppl 1):39-55. PubMed ID: 37955799
[TBL] [Abstract][Full Text] [Related]
6. Testing measurement properties of two EQ-5D youth versions and KIDSCREEN-10 in China.
Pei W; Yue S; Zhi-Hao Y; Ruo-Yu Z; Bin W; Nan L
Eur J Health Econ; 2021 Sep; 22(7):1083-1093. PubMed ID: 33893889
[TBL] [Abstract][Full Text] [Related]
7. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States.
Burström K; Teni FS; Gerdtham UG; Leidl R; Helgesson G; Rolfson O; Henriksson M
Pharmacoeconomics; 2020 Aug; 38(8):839-856. PubMed ID: 32307663
[TBL] [Abstract][Full Text] [Related]
8. Measurement properties and responsiveness of the EQ-5D-Y-5L compared to the EQ-5D-Y-3L in children and adolescents receiving acute orthopaedic care.
Verstraete J; Marthinus Z; Dix-Peek S; Scott D
Health Qual Life Outcomes; 2022 Feb; 20(1):28. PubMed ID: 35177084
[TBL] [Abstract][Full Text] [Related]
9. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?
Feng Y; Devlin N; Herdman M
Health Qual Life Outcomes; 2015 Oct; 13():171. PubMed ID: 26489956
[TBL] [Abstract][Full Text] [Related]
10. EQ-5D-Y-5L: developing a revised EQ-5D-Y with increased response categories.
Kreimeier S; Åström M; Burström K; Egmar AC; Gusi N; Herdman M; Kind P; Perez-Sousa MA; Greiner W
Qual Life Res; 2019 Jul; 28(7):1951-1961. PubMed ID: 30739287
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J
Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755
[TBL] [Abstract][Full Text] [Related]
12. EQ-5D-Y-3L and EQ-5D-Y-5L proxy report: psychometric performance and agreement with self-report.
Fitriana TS; Purba FD; Stolk E; Busschbach JJV
Health Qual Life Outcomes; 2022 Jun; 20(1):88. PubMed ID: 35659313
[TBL] [Abstract][Full Text] [Related]
13. How Well Does the EQ-5D-Y-5L Describe Children With Intellectual Disability?: "There's a Lot More to My Child Than That She Can't Wash or Dress Herself.".
Blackmore AM; Mulhern B; Norman R; Reddihough D; Choong CS; Jacoby P; Downs J
Value Health; 2024 Feb; 27(2):190-198. PubMed ID: 38043713
[TBL] [Abstract][Full Text] [Related]
14. Psychometric Properties of the EQ-5D-Y-5L for Children With Intellectual Disability.
Downs J; Norman R; Mulhern B; Jacoby P; Reddihough D; Choong CS; Finlay-Jones A; Blackmore AM
Value Health; 2024 Jun; 27(6):776-783. PubMed ID: 38467188
[TBL] [Abstract][Full Text] [Related]
15. A Comparison of the Psychometric Properties of the EQ-5D-Y-3L and EQ-5D-Y-5L Using Paediatric Multi-Instrument Comparison (P-MIC) Study Data.
Bahrampour M; Devlin N; Jones R; Dalziel K; Mulhern B;
Pharmacoeconomics; 2024 Jun; 42(Suppl 1):95-111. PubMed ID: 38748193
[TBL] [Abstract][Full Text] [Related]
16. Reporting and valuing one's own health: a think aloud study using EQ-5D-5L, EQ VAS and a time trade-off question among patients with a chronic condition.
Ernstsson O; Burström K; Heintz E; Mølsted Alvesson H
Health Qual Life Outcomes; 2020 Dec; 18(1):388. PubMed ID: 33334348
[TBL] [Abstract][Full Text] [Related]
17. Comparing measurement properties of EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients.
Fitriana TS; Purba FD; Rahmatika R; Muhaimin R; Sari NM; Bonsel G; Stolk E; Busschbach JJV
Health Qual Life Outcomes; 2021 Nov; 19(1):256. PubMed ID: 34781978
[TBL] [Abstract][Full Text] [Related]
18. EQ-5D-5L norms for the urban Chinese population in China.
Yang Z; Busschbach J; Liu G; Luo N
Health Qual Life Outcomes; 2018 Nov; 16(1):210. PubMed ID: 30409137
[TBL] [Abstract][Full Text] [Related]
19. Health problems are more common, but less severe when measured using newer EQ-5D versions.
Craig BM; Pickard AS; Lubetkin EI
J Clin Epidemiol; 2014 Jan; 67(1):93-9. PubMed ID: 24075597
[TBL] [Abstract][Full Text] [Related]
20. Cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany.
Eidt-Koch D; Mittendorf T; Greiner W
BMC Pediatr; 2009 Aug; 9():55. PubMed ID: 19715563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]